Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Type 2 diabetes specific considerations Individuals with type 2 diabetes starting tirzepatide often require adjustments to their existing diabetes medications
What makes GLP-1 particularly effective is that it only stimulates insulin when blood glucose levels are elevated, reducing the risk of hypoglycemia (low blood sugar)
This has implications for people with fatty liver disease who may not have significant obesity
Osteoarthritis Cartilage 26 , 10981109 (2018)
What is already known on this topic Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a promising drug class that has shown benefits for adults with type 2 diabetes Regulatory authorities have approved several GLP-1RA drugs, and novel drugs are continually emerging, resulting in an urgent need for updated evidence synthesis of the comparative effectiveness of various GLP-1RAs What this study adds Compared with the placebo, all 15 GLP-1RAs had significant effects on glycaemic control, and tirzepatide was the most effective in reducing haemoglobin A 1c and fasting plasma glucose concentrations CagriSema induced the highest weight reduction in adults with type 2 diabetes, followed by tirzepatide and retatrutide Several GLP-1RAs resulted in a significantly higher odds ratio of discontinuation due to adverse events than placebo, raising safety concerns about gastrointestinal adverse events, especially at high doses Ethics statements Ethical approval Not required
Im nervous about giving myself an injection
